Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Euro Log Regulatory News (ASLI)

Share Price Information for Abrdn Euro Log (ASLI)

Share Price is delayed by 15 minutes
Get Live Data
18.32    -0.26 (-1.40%)
Bid:
18.32
Ask:
18.68
Spread: 0.36 (1.965%)
Market Cap: £75.51m
ASLI Live PriceLast checked at - London Stock Exchange

Intraday Abrdn Euro Log Share Chart

B Share Scheme Apportionment Ratio

2 Apr 2025 07:00

RNS Number : 1377D
abrdn European Logistics Income plc
02 April 2025
 

abrdn European Logistics Income plc

2 April 2025

LEI: 213800I9IYIKKNRT3G50

B Share Scheme Apportionment Ratio

Further to the Company announcement dated 27 February 2025, abrdn European Logistics Income plc (the "Company") confirms the apportionment ratio in relation to the initial B share issue and the associated book cost. The Circular issued in relation to the B Share Scheme issued on 6 November 2024 may be found on the Company's website at: www.eurologisticsincome.co.uk in which Part 5 related to United Kingdom taxation.

 

Pursuant to the authority received from Shareholders at the general meeting held on 22 November 2024, the Board resolved to return approximately £16.5 million in aggregate to Shareholders via an issue of B Shares. On 7 March 2025 1,648,697,424 B Shares of one penny each were paid up from the Company's special distributable reserve and issued to all Shareholders by way of a bonus issue on the basis of 4 B Shares for every 1 Ordinary Share held at the Record Date of 6.00 p.m. on 6 March 2025.

 

The B Shares were immediately redeemed at their nominal value of one penny per B Share with a Redemption Date of 7 March 2025. The proceeds from the redemption of the B Shares, which is equivalent to 4 pence per Ordinary Share, were sent to uncertificated Shareholders through CREST with cheques posted to certificated Shareholders on 20 March 2025. Shareholders should note that no certificates were issued in respect of the B Shares.

 

For the purposes of United Kingdom taxation of capital gains and corporation tax on chargeable gains ("Capital Gains Tax"), the issue of B Shares constitutes a reorganisation of the share capital of the Company. Accordingly, the B Shares are treated as the same asset as a shareholder's holding of existing Ordinary shares, and as having been acquired at the same time as a shareholder's holding of existing Ordinary shares. A shareholder's combined holding of Ordinary shares and B shares has the same aggregate base cost as the shareholder's holding of Ordinary shares immediately before the issue of B shares. The aggregate base cost should be apportioned between B shares and the Ordinary shares held by a Shareholder by reference to the market values of the Ordinary shares and the B shares on the first day of trading after the issue of B shares.

 

Due to the terms on which the B Shares were issued and subsequently redeemed, and as they were unlisted and non-transferable, their market value has been assessed, below, as equal to their nominal value of one penny on 7 March 2025. The market value of the Ordinary shares is calculated with reference to their market value on the first day of trading after the issue of the B shares, which is considered to be 7 March 2025.

Accordingly, the aggregate base cost of the Ordinary shares which should be apportioned against the B Shares redemption proceeds, received by Shareholders on 20 March 2025 is 6.7%, calculated as follows:

 

Class of share

Market value on first day of trading

(pence per share)

Relevant ratio used for the issue of B Shares

Relevant value (pence per share)

Relevant percentage

Ordinary share*

55.8

1

55.8

93.3%

B Share

1

4

4

6.7%

 

* The lower of the two prices for an Ordinary share shown in the London Stock Exchange Daily Official List for 7 March 2025 as the closing price for an Ordinary share on that day plus one-half of the difference between those two figures in accordance with SI 2015/616.

 

United Kingdom taxation

The information above does not constitute tax advice and is intended only as a guide to United Kingdom law and HMRC published practice (which are both subject to change at any time, possibly with retrospective effect). It relates only to certain limited aspects of the United Kingdom taxation treatment of shareholders and is intended to apply only to shareholders who are resident in the United Kingdom for United Kingdom tax purposes and who are, and were the absolute beneficial owners of their Ordinary shares and B Shares and who hold, or held, them as investments (and not as securities to be realised in the course of a trade) other than under an ISA. The information above may not apply to certain shareholders, such as, but not limited to, dealers in securities, insurance companies, collective investment schemes and shareholders who are exempt from taxation. The position may be different for future transactions.

 

Shareholders who are in any doubt as to their tax position or who are subject to tax in a jurisdiction other than the United Kingdom should consult an appropriate professional adviser.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFVASIILIIE
Date   Source Headline
1st Jun 20263:56 pmRNSResult of AGM
28th May 20267:00 amRNSUnaudited Net Asset Value as at 31 March 2026
18th May 20269:38 amRNSConfirmation of €23.5m warehouse sale in Ede
6th May 20267:00 amRNSConditional sale and fourth interim dividend
28th Apr 202611:26 amRNSDoc re. Annual Report
24th Apr 20264:10 pmRNS5th capital distribution by way of B Share scheme
22nd Apr 20267:00 amRNSFinal Results
13th Apr 20267:00 amRNSUnaudited Net Asset Value as at 31 December 2025
20th Mar 20269:53 amRNSDisposal of Warehouse in Noves, France
16th Mar 20263:30 pmRNSDisposal of Dutch Asset
16th Mar 20263:30 pmRNSDisposal of Dutch Asset
20th Feb 202612:30 pmRNSResult of Requisitioned General Meeting
28th Jan 20267:00 amRNSPublication of Circular/Notice of General Meeting
23rd Jan 20269:00 amRNSDisposal of further French asset
12th Jan 20264:00 pmRNSNotice of Requisition of a General Meeting
12th Jan 20267:00 amRNSSale of French Assets
17th Dec 20257:00 amRNSResponse to DL Invest Group
2nd Dec 202510:40 amRNS4th capital distribution by way of B Share scheme
27th Nov 20253:33 pmRNSHolding(s) in Company
20th Nov 20257:00 amRNSAnnouncement of Interim Dividend
3rd Nov 20257:00 amRNSSale of Polish Assets
27th Oct 20257:00 amRNSEstimated Unaudited NAV as at 30 September 2025
22nd Oct 202510:23 amRNSHolding(s) in Company
20th Oct 20254:00 pmRNSHolding(s) in Company
20th Oct 20254:00 pmRNSHolding(s) in Company
13th Oct 202511:59 amRNSDoc re. Half Yearly Report
29th Sep 20257:00 amRNSHalf-year Report
3rd Sep 20255:35 pmRNSReplacement Unaudited NAV as at 30 June 2025
3rd Sep 20257:00 amRNSUnaudited NAV as at 30 June 2025
29th Aug 20257:00 amRNSThird B Share Distribution
18th Aug 20259:35 amRNSDeclaration of Interim Distribution
6th Aug 20257:00 amRNSContinued Sales Momentum & Disposal Process Update
31st Jul 20257:00 amRNSPortfolio Sales Update
16th Jul 20259:24 amRNSPortfolio Sales and Second B Share Distribution
11th Jul 202511:44 amRNSHolding(s) in Company
11th Jul 20257:00 amRNSPortfolio Sales Update
2nd Jul 20253:33 pmRNSReplacement Result of AGM
25th Jun 20252:15 pmRNSResult of AGM
11th Jun 202510:20 amRNSHolding(s) in Company
28th May 20257:00 amRNSUnaudited NAV as at 31 March 2025
19th May 202510:02 amRNSFirst Interim Dividend Declaration
6th May 202510:18 amRNSDirector Declaration
1st May 20254:22 pmRNSDoc re. Annual Report
11th Apr 20257:00 amRNSAnnual Financial Report
2nd Apr 20257:00 amRNSB Share Scheme Apportionment Ratio
26th Mar 20252:52 pmRNSHolding(s) in Company
27th Feb 20257:00 amRNSB Share Scheme First Distribution
24th Feb 20257:00 amRNSUnaudited Net Asset Value as at 31 December 2024
17th Feb 20257:00 amRNSFourth Interim Distribution
29th Jan 20254:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.